Literature DB >> 308512

Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.

R B Counts, S L Paskell, S K Elgee.   

Abstract

Human Factor VIII/von Willebrand factor, purified by calcium citrate-cellulose chromatography and 4% agarose gel filtration was subjected to sodium dodecyl sulfate gel electrophoresis on gels containing 2% acrylamide and 0.5% agarose. We find a series of multimers of which the apparent molecular weight of the higher members was congruent with5 million. The higher multimers were isolated by 2% agarose gel filtration. Treatment of the high molecular weight multimers with 2-mercaptoethanol at concentrations of 0.005-0.5% in the presence of 1% dodecyl sulfate resulted in a shift to lower molecular weight multimers. Between mercaptoethanol concentrations of 0.01 and 0.5%, the predominant species was the dimer of the basic subunit. Mercaptoethanol concentrations >0.5% were required to reduce the interchain disulfide bonds of the dimer. An artificial multimeric series was prepared by cross-linking von Willebrand factor subunits with dimethylsuberimidate. Comparison of the multimers produced by reduction with the multimers produced by cross-linking, demonstrated the absence of odd-numbered multimers from the reduced series. Thus, the protomeric unit appears to be the dimer. High molecular weight multimers had both ristocetin cofactor activity and Factor VIII procoagulant activity. Reduction of the protein in the absence of denaturing agents, caused a gradual shift to lower molecular weight species and a concomitant loss of von Willebrand factor activity. In contrast, Factor VIII activity was unchanged by reduction. These studies suggest that the moieties having von Willebrand factor activity and those having Factor VIII activities are covalently linked by disulfide bonds.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308512      PMCID: PMC371817          DOI: 10.1172/JCI109178

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Solid-phase immunoradiometric assay of factor-VIII protein.

Authors:  R B Counts
Journal:  Br J Haematol       Date:  1975-12       Impact factor: 6.998

2.  The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.

Authors:  W J Brockway; D N Fass
Journal:  J Lab Clin Med       Date:  1977-06

3.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

4.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

5.  A brain extract as a substitute for platelet suspensions in the thromboplastin generation test.

Authors:  W N BELL; H G ALTON
Journal:  Nature       Date:  1954-11-06       Impact factor: 49.962

6.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Formation of a serine enzyme in the presence of bovine factor VIII (antihemophilic factor) and thrombin.

Authors:  G A Vehar; E W Davie
Journal:  Science       Date:  1977-07-22       Impact factor: 47.728

9.  Immunological evidence that human factor VIII is composed of two linked moieties.

Authors:  J Koutts; J M Lavergne; D Meyer
Journal:  Br J Haematol       Date:  1977-11       Impact factor: 6.998

10.  Purification of porcine and human ristocetin-Willebrand factor.

Authors:  J D Olson; W J Brockway; D N Fass; E J Bowie; K G Mann
Journal:  J Lab Clin Med       Date:  1977-06
View more
  22 in total

1.  Subunit structure and assembly of von Willebrand factor polymer: complementary analysis by electron microscopy and quasielastic light scattering.

Authors:  J Loscalzo; H Slayter; R I Handin; D Farber
Journal:  Biophys J       Date:  1986-01       Impact factor: 4.033

2.  Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.

Authors:  E J Bowie; L A Solberg; D N Fass; C M Johnson; G J Knutson; M L Stewart; L J Zoecklein
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 3.  Factor VIII/von Willebrand factor: a multivalent ligand binding to platelets and collagen.

Authors:  M Furlan
Journal:  Blut       Date:  1986-06

4.  Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells.

Authors:  D C Lynch; R Williams; T S Zimmerman; E P Kirby; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

5.  Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

Review 6.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

7.  The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.

Authors:  A Leyte; J Voorberg; H B Van Schijndel; B Duim; H Pannekoek; J A Van Mourik
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

8.  Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.

Authors:  M Furlan; R Robles; D Affolter; D Meyer; P Baillod; B Lämmle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).

Authors:  Z M Ruggeri; I M Nilsson; R Lombardi; L Holmberg; T S Zimmerman
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.

Authors:  K K Hamilton; L J Fretto; D S Grierson; P A McKee
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.